	Annexin A2 as a marker for hepatocellular carcinoma detection among patients with hepatitis C virus-related liver cirrhosis after HCV treatment using directly acting antivirals. Clin Exp Hepatol Shater MS, Abd Elmoety AA, Rostom YAA, Elkemary EZ, Helal HM, Kamal A. PMID: 42022000 [PubMed]
	Identification of novel therapeutic targets for liver fibrosis, cirrhosis, and hepatocellular carcinoma via dual-omics analysis and preliminary exploration of regulatory mechanisms. Clin Exp Hepatol Chen J, Cao R, He Z, Li Z, Hong Y, Ren C, Wang Y, Wu J, Liu Y, Xia H. PMID: 42021999 [PubMed]
	[Chronic abdominal pain in elderly patient]. Praxis (Bern 1994) Trepp S, Zimmerli L. PMID: 42021674 [PubMed - indexed for MEDLINE]
	The LiverCare intervention: implementing structured palliative care in hepatology - a multicenter mixed-methods feasibility study in patients with cirrhosis. BMC Palliat Care Grønkjær LL, Jacobsen BG, Teisner AS, Bager P, Hamberg ML, Mendahl J, Marsaa K, Guldin MB, Kimer N, Lauridsen MM, O Connell MB. PMID: 42021258 [PubMed - as supplied by publisher]
	Impact of liver cirrhosis etiology on results of diagnostic tests for minimal hepatic encephalopathy. Sci Rep Egge JFM, Ehrenbauer AF, Gabriel MM, Tiede A, Al-Ayoubi J, Witt J, Mauz JB, Kabelitz MA, Wagner LS, Wedemeyer H, Grosshennig A, Grosse GM, Maasoumy B, Weissenborn K. PMID: 42020485 [PubMed - in process]
	Delisting for clinical improvement as a proxy for recompensated cirrhosis on the U.S. liver transplant waitlist: A retrospective cohort study. Liver Transpl McCullough AA, Mahmud N, Reddy KR, Bittermann T. PMID: 42019004 [PubMed - as supplied by publisher]
	Micronutrient deficiencies in hepatic cirrhosis: Navigating challenges to assessment and implications for clinical management: A narrative review. Nutr Clin Pract Estes-Doetsch H, Wellner M, Ziegler J. PMID: 42017443 [PubMed - as supplied by publisher]
	Transient elastography in acute hospital inpatients with harmful alcohol use: a service evaluation. Alcohol Alcohol Balston AJ, Conti I, Darko S, Gajendran L, Quashie S, Mohamed S, Krzanowski J, Wang B, Archer J. PMID: 42014376 [PubMed - indexed for MEDLINE]
	Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study. Aliment Pharmacol Ther Palom A, Degasperi E, Coco B, Loglio A, Ciancio A, Niro GA, Riveiro-Barciela M, Carvalho-Gomes A, García-Samaniego J, Lens S, Rando-Segura A, Sambarino D, Cotugno R, Kondili LA, Brunetto M, Viganò M, Lampertico P, Buti M. PMID: 42010908 [PubMed - as supplied by publisher]
	Albumin Restores Endothelial Cell Mitochondrial Morphology in Patients With Decompensated Cirrhosis. Liver Int Fischer SE, Postma RJ, Bijkerk R, Kerbert AJC, van Zonneveld AJ, Coenraad MJ. PMID: 42010744 [PubMed - indexed for MEDLINE]
	Exploratory longitudinal cohort study of modest bilirubin-driven biochemical liver alterations after SARS-CoV-2 infection in a selected subgroup of patients with Wilson's disease and liver cirrhosis. BMC Gastroenterol Köhrer S, Brand ML, Leidner V, Zimmer H, Langel A, Langel J, Michl P, Mohr I. PMID: 42010493 [PubMed - in process]
	Successful Living Donor Liver Transplant Following Roux-en-Y Gastric Bypass in a Patient With Super Obesity With Hepatitis B Virus-Related Cirrhosis: A 7-Year Follow-Up Case Report. Exp Clin Transplant Tuncer A, Ogut MZ, Usta S, , Kayaalp C, Yilmaz S. PMID: 42007861 [PubMed - indexed for MEDLINE]
	Alterations in Primary Haemostasis in Patients With Liver Cirrhosis and Bacterial Infection. Liver Int Athanasaki F, Vasilieva L, Pavlou E, Formozis S, Dimitriou K, Krystallaki D, Karamanolis NN, Mani I, Kontopidou F, Hadziyannis E, Nomikou E, Alexopoulou A. PMID: 42007664 [PubMed - indexed for MEDLINE]
	Population Pharmacokinetics and Pharmacokinetics-Pharmacodynamics Analyses of Elafibranor to Support Dose Selection in Primary Biliary Cholangitis. CPT Pharmacometrics Syst Pharmacol Ooi QX, Brendel K, van Beek S, Zdovc JA, Bardol M, Dehez M. PMID: 42007495 [PubMed - indexed for MEDLINE]
	Predictive value of liver fibrosis markers and model for end-stage liver disease score in evaluating the degree of esophageal and gastric varices in cirrhosis. Am J Transl Res Liu L, Chang Y, Wang H. PMID: 42007148 [PubMed]
	The MASLD Journey in the General Population: Linkage-to-Care and Patient-Reported Uptake of Fibrosis Risk Assessment. Liver Int Oh JH, Lee JH, Ahn SB, Kwon E, Yoon EL, Lee HY, Cho S, Jun DW. PMID: 42003526 [PubMed - indexed for MEDLINE]
	Emerging Diagnostic Tools and Therapeutic Approaches for Liver Cirrhosis Management. Curr Pharm Des Mukherjee S, Kumar M, Das S, Shafi S, Srivastava S, Mishra MK, Singh AK, Pal RR. PMID: 42003186 [PubMed - as supplied by publisher]
	Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship. Lancet Gastroenterol Hepatol Jalan R, Patel VC, Shoaie S. PMID: 42001877 [PubMed - as supplied by publisher]
	Concurrent hepatic cirrhosis and chronic lymphocytic leukemia: a challenging coexistence: a case report. J Med Case Rep Mahani FK, Nezhad NZ, Ghaderi R, Jafari E, Khazaeli M, Kermanshahaninejad SO, Shamsinejad B. PMID: 42001129 [PubMed - indexed for MEDLINE]
	From Cure to Complexity: Post-SVR Liver and Metabolic Trajectories in Diabetic Patients. Liver Int Asero C, Franzè MS, Maltese T, La Spada A, Lombardo D, Grisanti C, Russo G, Giandalia A, Pitrone C, Filomia R, Caccamo G, Saitta C, Licata A, Pollicino T, Cacciola I. PMID: 41999061 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 38366

Page 1 of 1919



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy